Cart
0
 
 

Neurovascular Devices Market by Product [Embolization Devices (Clippings, Embolic Coils, Coil Assist Stents, and Coil Assist Balloon), Revascularization Devices (Carotid Artery Stents and Flow Diversion Stents), Accessory Devices (Microcatheters and Microguidewires), Thrombectomy Devices (Clot Retrieval Devices, Suction & Aspiration Devices, and Snares), and Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices)], and Disease Pathology [Aneurysm, Arteriovenous Malformation & Fistulas (AVM), Ischemic Stroke, and Stenosis]: Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
Medical Devices & Supplies
LI_172278
Pages: 150
May 2017 | 1651 Views
 
Author's : Prateeksha Kaul & Garima Chandra
Tables: 72
Charts: 40
 

Neurovascular Devices Market Overview:

Global Neurovascular Devices Market was valued at $2,371 million in 2016, and is estimated to reach $3,409 million by 2023, growing at a CAGR of 5.3% during the study period. Neurovascular devices (such as coils) aid in treatment of various neurovascular disorders such as cerebral aneurysms and intracranial atherosclerotic disease. Rise in geriatric population and upsurge in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, increase in adoption of new minimally invasive techniques such as flow diversion and carotid artery stenting boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.

Rise in Incidence of Neurovascular Disorders and Geriatric Population

As per the estimates of the Centers for Disease Control and Prevention, more than 795,000 people in the U.S. suffer from stroke every year. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). For instance, according to The Internet Stroke Center, nearly 75% of strokes occur in people over the age of 65. Moreover, the risk of having a stroke doubles after the age of 55.

Growth in Asia-Pacific Region

Asia-Pacific offers lucrative opportunities for the growth market owing to presence of large pool of patients suffering from neurovascular disorders such as stenosis, AVM, and strokes. According to a journal published by Public Library of Science (PLOS) in 2013, China is estimated to have 2.5 million new stroke cases every year. Hence, high incidence of stroke and aneurysm makes it an attractive market for neurovascular devices.

Innovation in Treatment

The market has witnessed evolution of innovative treatment techniques, which in turn has improved the management of neurovascular disorders. For instance, with the introduction of flow diversion stent, the need to treat aneurysms with complex bypasses has dropped significantly.

Global Neurovascular Devices Market Segmentation

Global Neurovascular Devices Market Segmentation

Get more information on this report : Request Sample Pages

The global neurovascular devices market is segmented on the basis of product, disease pathology, and region. Based on product, the market is classified into embolization devices, revascularization devices, accessory devices, thrombectomy devices, and emboli protection devices. By disease pathology, it is divided into aneurysm, arteriovenous malformation & fistulas (AVM), ischemic stroke, and stenosis. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include Stryker Corporation, Medtronic Plc., Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., and W.L. Gore & Associates, and Acandis GmbH & Co. KG.

South Africa: Neurovascular Devices Market, 2016-2023 ($Million)

South Africa: Neurovascular Devices Market, 2016-2023 ($Million)

Get more information on this report : Request Sample Pages

Key Benefits

  • The study provides an in-depth analysis of the global neurovascular devices market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Neurovascular Devices Market Key Segments:

By Product

  • Embolization Devices
    • Clippings
    • Embolic Coils
      • Bare Detachable Coils
      • Coated Detachable Coils
    • Coil Assist Stent
  • Revascularization Devices
    • Carotid Artery Stents
    • Flow Diversion Stents
  • Accessory Devices
    • Microcatheters
    • Microguidewires
  • Thrombectomy Devices
    • Clot Retrieval Devices
    • Suction & Aspiration Devices
    • Snares
  • Embolic Protection Devices
    • Distal Filter Devices
    • Balloon Occlusion Devices

By Disease Pathology

  • Aneurysm
  • Arteriovenous Malformation and Fistulas (AVM)
  • Ischemic Stroke
  • Stenosis

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rising geriatric population
3.4.1.2. Increasing prevalence of neurovascular disorders
3.4.1.3. Technological advancement

3.4.2. Restraints

3.4.2.1. High cost
3.4.2.2. Dearth of neurosurgeons

3.4.3. Opportunities

3.4.3.1. Emerging nations

Chapter: 4 NEUROVASCULAR DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EMBOLIZATION DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Clippings

4.2.3.1.1. Market size and forecast

4.2.3.2. Embolic Coils

4.2.3.2.1. Market size and forecast
4.2.3.2.2. Bare Detachable Coils

4.2.3.2.2.1. Market size and forecast

4.2.3.2.3. Coated Detachable Coils

4.2.3.2.3.1. Market size and forecast

4.2.3.3. Coil assist stent

4.2.3.3.1. Market size and forecast

4.2.3.4. Coil assist balloon

4.2.3.4.1. Market size and forecast

4.3. REVASCULARIZATION DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Carotid Artery Stents

4.3.3.1.1. Market size and forecast

4.3.3.2. Flow Diversion Stents

4.3.3.2.1. Market size and forecast

4.4. ACCESSORY DEVICES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.4.3.1. Microcatheters

4.4.3.1.1. Market size and forecast

4.4.3.2. Microguidewires

4.4.3.2.1. Market size and forecast

4.5. THROMBECTOMY DEVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.5.3.1. Clot Retrieval Devices

4.5.3.1.1. Market size and forecast

4.5.3.2. Suction and Aspiration Devices

4.5.3.2.1. Market size and forecast

4.5.3.3. Snares

4.5.3.3.1. Market size and forecast

4.6. EMBOLIC PROTECTION DEVICES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.6.3.1. Distal Filter Devices

4.6.3.1.1. Market size and forecast

4.6.3.2. Balloon Occlusion Devices

4.6.3.2.1. Market size and forecast

Chapter: 5 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ANEURYSM

5.2.1. Market size and forecast

5.3. ARTERIOVENOUS MALFORMATION (AVM)

5.3.1. Market size and forecast

5.4. ISCHEMIC STROKE

5.4.1. Market size and forecast

5.5. STENOSIS

5.5.1. Market size and forecast

Chapter: 6 NEUROVASCULAR DEVICES MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. ACANDIS GMBH & CO. KG

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)

7.2. JOHNSON & JOHNSON

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)

7.3. INTEGER HOLDINGS CORPORATION

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)

7.4. MEDTRONIC PLC

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)

7.5. MERIT MEDICAL SYSTEMS

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)

7.6. MICROPORT SCIENTIFIC CORPORATION

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)

7.7. PENUMBRA, INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)

7.8. STRYKER CORPORATION

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)

7.9. TERUMO CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)

7.10. W.L. GORE & ASSOCIATES

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)

LIST OF TABLES

TABLE 1. GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL EMBOLIZATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. GLOBAL EMBOLIC COILS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 4. EMBOLIZATION DEVICES MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 5. NORTH AMERICA EMBOLIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 6. EUROPE EMBOLIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 7. ASIA-PACIFIC EMBOLIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 8. LAMEA EMBOLIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 9. GLOBAL EMBOLIC COILS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 10. GLOBAL REVASCULARIZATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. REVASCULARIZATION DEVICES MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 12. NORTH AMERICA REVASCULARIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 13. EUROPE REVASCULARIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 14. ASIA-PACIFIC REVASCULARIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 15. LAMEA REVASCULARIZATION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 16. GLOBAL ACCESSORY DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 17. ACCESSORY DEVICES MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA ACCESSORY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 19. EUROPE ACCESSORY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 20. ASIA-PACIFIC ACCESSORY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 21. LAMEA ACCESSORY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 22. GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 23. THROMBECTOMY DEVICES MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA THROMBECTOMY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 25. EUROPE THROMBECTOMY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 27. LAMEA THROMBECTOMY DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 28. GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. EMBOLIC PROTECTION DEVICES MARKET, BY REGION 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 31. EUROPE EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 33. LAMEA EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 35. NEUROVASCULAR DEVICES MARKET FOR ANEURYSM, BY REGION, 2016-2023 ($MILLION)
TABLE 36. NEUROVASCULAR DEVICES MARKET FOR AVM, BY REGION, 2016-2023 ($MILLION)
TABLE 37. NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY REGION, 2016-2023 ($MILLION)
TABLE 38. NEUROVASCULAR DEVICES MARKET FOR STENOSIS, BY REGION, 2016-2023 ($MILLION)
TABLE 39. NEUROVASCULAR DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 40. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 41. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 42. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 44. EUROPE NEUROVASCULAR DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 45. EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 46. EUROPE NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 50. LAMEA NEUROVASCULAR DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 51. LAMEA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 52. LAMEA NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2016-2023 ($MILLION)
TABLE 53. ACANDIS: COMPANY SNAPSHOT
TABLE 54. ACANDIS: OPERATING SEGMENTS
TABLE 55. J&J: COMPANY SNAPSHOT
TABLE 56. J&J: OPERATING SEGMENTS
TABLE 57. INTEGER: COMPANY SNAPSHOT
TABLE 58. INTEGER: OPERATING SEGMENTS
TABLE 59. MEDTRONIC: COMPANY SNAPSHOT
TABLE 60. MEDTRONIC: OPERATING SEGMENTS
TABLE 61. MERIT: COMPANY SNAPSHOT
TABLE 62. MERIT: OPERATING SEGMENTS
TABLE 63. MICROPORT: COMPANY SNAPSHOT
TABLE 64. MICROPORT: OPERATING SEGMENTS
TABLE 65. PENUMBRA: COMPANY SNAPSHOT
TABLE 66. PENUMBRA: OPERATING SEGMENTS
TABLE 67. STRYKER: COMPANY SNAPSHOT
TABLE 68. STRYKER: OPERATING SEGMENTS
TABLE 69. TERUMO: COMPANY SNAPSHOT
TABLE 70. TERUMO: OPERATING SEGMENTS
TABLE 71. W.L. GORE: COMPANY SNAPSHOT
TABLE 72. W.L. GORE: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL NEUROVASCULAR DEVICES MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL NEUROVASCULAR DEVICES MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL NEUROVASCULAR DEVICES MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 8. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 9. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 10. MARKET SHARE ANALYSIS, 2016
FIGURE 11. IMPACT ANALYSIS, NEUROVASCULAR DEVICES MARKET
FIGURE 12. GLOBAL CLIPPINGS MARKET, 2016-2023 ($MILLION)
FIGURE 13. GLOBAL BARE DETACHABLE COILS MARKET, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL COATED DETACHABLE COILS MARKET, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL COIL ASSIST STENT MARKET, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL COIL ASSIST BALLOON MARKET, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL CAROTID ARTERY STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL CAROTID ARTERY STENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL MICROCATHETERS MARKET, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL MICROGUIDEWIRES MARKET, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL CLOT RETRIEVAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. GLOBAL SUCTION AND ASPIRATION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. GLOBAL SNARES MARKET, 2016-2023 ($MILLION)
FIGURE 24. GLOBAL DISTAL FILTER DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 25. GLOBAL BALLOON OCCLUSION DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 27. GLOBAL NEUROVASCULAR DEVICES MARKET FOR ANEURYSM, 2016-2023 ($MILLION)
FIGURE 28. GLOBAL NEUROVASCULAR DEVICES MARKET FOR AVM, 2016-2023 ($MILLION)
FIGURE 29. GLOBAL NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, 2016-2023 ($MILLION)
FIGURE 30. GLOBAL NEUROVASCULAR DEVICES MARKET FOR STENOSIS, 2016-2023 ($MILLION)
FIGURE 31. ACANDIS: FINANCIALS
FIGURE 32. DANAHER: FINANCIALS
FIGURE 33. INTEGER: FINANCIALS
FIGURE 34. MEDTRONIC: FINANCIALS
FIGURE 35. MERIT: FINANCIALS
FIGURE 36. MICROPORT: FINANCIALS
FIGURE 37. PENUMBRA: FINANCIALS
FIGURE 38. STRYKER: FINANCIALS
FIGURE 39. TERUMO: FINANCIALS
FIGURE 40. W.L. GORE: FINANCIALS
 

Globally, neurovascular disorders such as aneurysms, stenosis, and arteriovenous malformations (AVMs) constitute a major proportion of health and economic burden. Hence, the adoption of neurovascular devices is vital for effective treatment of these disorders.

Upsurge in the incidence of neurovascular disease such as stroke and increase in geriatric population have led to high adoption of neurovascular devices. In addition, introduction of innovative treatment techniques such as carotid artery and flow diversion stenting has further led to the market growth.

Asia-Pacific offers lucrative opportunities for the market growth due to increase in healthcare expenditure, rapid increase in geriatric population, and rise in incidence of neurovascular disease. Thus, emerging economies such as China and India possess high growth potential for this market.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Neurovascular Devices Market

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
Connect To Analyst
 

FREQUENTLY ASKED
QUESTIONS?

 
Read More
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
Request Customization
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
report-img

Published in  Aug 2018

PEGylated Protein Therapeutics Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
report-img

Published in  Jul 2018

Cytogenetics Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
report-img

Published in  Jul 2018

Asia-Pacific IVF Services Market- Global Opportunity Analysis and Industry Forecast, 2018-2028

Download Sample
report-img

Published in  Jul 2018

Anticoagulants Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo